Cart
sales@molnova.com
MK-?0955 calcium
CAS No. 26472-47-9
MK-?0955 calcium( —— )
Catalog No. M13811 CAS No. 26472-47-9
Fosfomycin calcium is an antibiotics, used in urinary tract infections and intestinal infections caused by susceptible strains.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | In Stock |
|
| 10MG | 49 | In Stock |
|
| 25MG | 88 | In Stock |
|
| 50MG | 123 | In Stock |
|
| 100MG | 165 | In Stock |
|
| 200MG | 230 | In Stock |
|
| 500MG | 386 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-?0955 calcium
-
NoteResearch use only, not for human use.
-
Brief DescriptionFosfomycin calcium is an antibiotics, used in urinary tract infections and intestinal infections caused by susceptible strains.
-
DescriptionFosfomycin calcium is an antibiotics, used in urinary tract infections and intestinal infections caused by susceptible strains.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26472-47-9
-
Formula Weight176.12
-
Molecular FormulaC3H5CaO4P
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESC[C@H]1[C@H](O1)P(=O)([O-])[O-].[Ca+2]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Angiotensin I/II 1-6
Angiotensin I/II (1-6) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS) that contains the amino acids 1-6 and is converted from Angiotensin I/II peptide.
-
8-Hydroxy-5,7-dimeth...
8-Hydroxy-5,7-dimethoxyflavanone represents a useful tumor-preventive phytochemical that triggers p53-driven G2/M cell cycle arrest and apoptosis.PDMF(8-Hydroxy-5,7-dimethoxyflavanone) as a new potent anti-allergic phytochemical useful for prevention of IgE-driven hypersensitivity reactions.8-hydroxy-5,7-dimethoxyflavanone has anti-inflammatory activity.
-
Chrysotobibenzyl
Chrysotobibenzyl can be isolated from stem of Dendrobium pulchellum. Chrysotobibenzyl inhibits lung cancer cell (H460 and H292) migration, invasion, filopodia formation via Cav-1, integrins β1, β3, and αν, and EMT suppressions. Chrysotobibenzyl also sensitizes lung cancer cell death mediated by Cisplatin.
